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Abstract
Objectives The aim of this study was to explore pharmacists’ barriers and facil-
itators regarding participation in pharmacy practice research.
Methods We conducted an online cross-sectional survey in 1974 community
pharmacies in the Netherlands.
Key findings A total of 252 pharmacists completed the questionnaire. The
majority agreed that participation in research should be part of daily practice.
Efficient time investment and a clear benefit for general professional knowledge,
patient care and pharmacy organisation were the most important facilitating
factors.
Conclusions To encourage pharmacists’ participation, researchers should offer
clear instructions, possibilities for flexible time management, simple patient
inclusion, task delegation and no additional contacts with healthcare profes-
sionals due to the research.
Introduction
Effective primary care, based on the relationship between
healthcare professional and patient, requires practice
research to examine the need, effectiveness and efficiency
of specific services that will provide evidence to inform
best practices.[1,2] In the past decades, community phar-
macy practice has extended the traditional role of dis-
pensing medication to one including provision of
patient-centred pharmaceutical care.[2,3] However, con-
ducting practice research and recruiting healthcare
professionals to participate in the practice can be chal-
lenging. It is essential to accurately grasp pharmacists’
views and potential barriers, and prevent dropouts dur-
ing studies.4 Previous studies have not specifically tar-
geted community pharmacists, and the study results may
be outdated.2,5–7
The present study aimed to identify community phar-
macists’ barriers and facilitators in considering participa-
tion in pharmacy practice research in the Netherlands. It
did so by describing these pharmacists’ views and atti-
tudes so as to provide researchers with insight on how to
optimise research participation.
Method
Setting
Pharmacy students and community pharmacists in the
Netherlands are trained to perform research and are regu-
larly invited to participate in pharmacy practice research.
Survey
A cross-sectional survey was performed in 2017. All
pharmacists from 1974 community pharmacies in the
Netherlands[8] were invited to complete a 35-item ques-
tionnaire. Statements regarding views and attitudes were
scored on a 10-point Likert scale. Statements were based
on literature[2,5–7] and researchers’ experiences, and all
of the present study’s authors checked them for face
validity.
A specific example of a pharmacy practice study was
also developed to explore the willingness to participate by
varying the (extent of) different potential barriers. The
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questionnaire ended with an open-ended question on key
factors for participation.
No personal identifiers were collected.
Data collection
An e-mail invitation to participate in the survey was sent
in July 2017. Non-responders were sent a reminder
1 week later. Data collection were completed at the end
of the same month.
Data analysis
Quantitative data were analysed using descriptive statis-
tics. For each statement, the median and interquartile
range were calculated, together with numbers of
pharmacists who noted scores of 1 or 2 and 9 or 10. Two
of the authors (EK and MT) independently coded and
summarised qualitative responses to the open-ended ques-
tion to identify key topics via the grounded theory
approach.9 Disagreements were discussed until consensus
was reached.
Results
The questionnaire was completed by 252 of the 2968 con-
tacted pharmacists; response rate: 8.8%. Their mean age
was 43.7 years, and nearly 48% had recently participated
in practice research (within the preceding year).
Table 1 shows the pharmacists’ general views and atti-
tudes regarding pharmacy practice research. A majority
(85.6%) agreed (score: 7–10 points) that practice research
Table 1 Pharmacists’ views and attitudes regarding practice research
Statement Median (IQR)
Number of
respondents
score 1 or 2a
Number of
respondent
score 9 or 10 Agree (%)b
Participation in pharmacy practice research belongs to the profession of every
community pharmacist
8 (2) 13 57 179 (71.0%)
Participation in pharmacy practice research belongs to the education of a
community pharmacy specialist
8 (2) 10 88 220 (87.3%)
Without pharmacy practice research the specialism of the community
pharmacist cannot exist for the long term
7 (2) 17 54 162 (64.3%)
Pharmacy practice research provides evidence-based insights into the actions
of the community pharmacist
8 (2) 7 83 216 (85.7%)
Pharmacy practice research provides insights into future opportunities for the
profession of the community pharmacist
8 (2) 4 75 209 (82.9%)
I would like to participate in pharmacy practice research, but it is too busy in
the pharmacy
7 (3) 28 47 139 (55.2%)
I only participate in pharmacy practice research if the subject is interesting
enough for me
8 (1) 8 55 198 (78.6%)
If the subject is also important for the general practitioners (GP’s) I am
working with, I only participate if patients’ GP has no objections
7 (4) 31 36 127 (50.4%)
I am willing to find time to participate in pharmacy practice research 7 (3) 20 25 130 (51.6%)
I only participate in pharmacy practice research if have confidence in the
investigators
8 (2) 5 73 190 (75.4%)
I only participate in pharmacy practice research if it is obliged (e.g. during
education)
4 (4) 80 6 38 (15.1%)
If I participate in pharmacy practice research depends on my employer 5 (5.75) 73 25 84 (33.3%)
I only participate in pharmacy practice research if I know the investigators
personally
3 (3) 124 0 6 (2.4%)
I am convinced of the added value of pharmacy practice research 8 (2) 4 65 192 (76.2%)
Participating in pharmacy practice research. . .
Is generally interesting for me 7 (2) 13 49 188 (74.6%)
Gives me opportunities for personal development as a pharmacist 8 (2) 11 46 183 (72.6%)
Is feasible in the pharmacy where I am working 7 (3) 22 28 128 (50.8%)
Is usual procedure in the pharmacy where I am working 5 (3) 63 17 73 (29%)
Is stimulated by colleagues or the professional group 6 (3) 29 12 83 (32.9%)
Can help me to improve patient care and my relation with patients 7 (2) 6 29 167 (66.3%)
Can help me to improve my position as healthcare professional 8 (2) 4 65 202 (80.2%)
IQR, interquartile range.
aTotal number of respondents per statement: 252. bScores 7–10.
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provided evidence-based insight into the activities of
community pharmacists and opportunities for profes-
sional development. A majority (71%) also agreed that
participation in practice research in general is a natural
part of the pharmacists’ profession.
Almost 51% of the respondents felt participation was
feasible in daily practice, and 29% regarded participation
as common for their daily practice. Additionally, 55%
indicated they would like to participate but lacked the
time to do so. Important facilitators were confidence in
the investigators and interest in the study topic (75.4%
and 78.6% agreement, respectively). Although a majority
(76%) of the respondents reported being convinced of the
general added value of pharmacy practice research, only
52% indicated they were prepared to invest the time to
participate.
The surveyed pharmacists expressed they were more
likely to participate in practice research when the
requested work could be spread over some weeks rather
than performed in 1 day (77.4% versus 35.3%, respec-
tively; Table 2). They also preferred the possibility of del-
egating tasks (e.g. to their pharmacy technicians) over
performing all procedures themselves (90.9% versus
61.9%, respectively). They were more likely to participate
when patients could be invited by email (86.8%) instead
of personally during pharmacy visits or by telephone
(65.9%). Pharmacists can access patients’ email addresses,
as most pharmacies offer digital services (e.g. track and
trace). The need to cooperate with medical specialists dis-
couraged more than half of the surveyed pharmacists;
only 48% would participate, compared with 73.8% when
cooperation only with general practitioners was required.
A total of 415 key factors for participation were men-
tioned. The cluster of factors identified most fre-
quently were total time investment, timing of the study
and the possibility of flexible time needed to participate
(n = 142). These were followed by need for clear added
value (for the profession, the patient and the pharmacy
practice or pharmacist, n = 104). Specifically mentioned
positive factors (n = 67) were simple patient selection and
data collection, no need for cooperation with many differ-
ent healthcare professionals, a clear and complete descrip-
tion of the required tasks, no collection of superfluous
data, and reliable explanation of the study and the activi-
ties required.
Discussion
The present study results offer clear guidance for design-
ing pharmacy practice studies. Researchers should pay
close attention to efficient time investment and study
logistics, for example possibilities of inviting patients by
email, delegating tasks and spreading out time investment.
This study corroborates results of earlier studies.2,10 When
pharmacists were convinced of a study’s added value and
feasibility, they reported willingness to invest their time,
even when no financial compensation was available. How-
ever, obligated contact and cooperation with other health-
care professionals was a discouraging factor in participating
in practice research.
A limitation in the present survey was the low-response
rate, which reflected the problem addressed herein. As
expected, respondents had recently participated in phar-
macy practice research. The results cannot be generalised
to all community pharmacists because of this selection
bias. However, the opinions of experienced and interested
respondents were of great importance. Committed phar-
macists experienced limited support from colleagues or
professional organisations; thus, there are still possibilities
to actively boost participation.
Table 2 Case: organisational factors and influence on participation (n = 252)
You are invited to participate in a pharmacy practice study about the implementation of specific clinical rules. You have to include five patients,
obtain their informed consent and collect data as well by a short questionnaire as from the pharmacy information system. The anonymous data
have to be registered in a predefined form and should be sent digitally to the investigators. The estimated total time investment is about 5 hours
Would you participate in the described study if: Yes (%)
The total investment of time has to be done on 1 day? 89 (35.3)
The total investment of time has to be spread over a period of 3 weeks? 195 (77.4)
The study has to be finished within 4 weeks from now? 169 (67.1)
The study has to be finished within 12 weeks from now? 200 (79.4)
All tasks have to be done by the pharmacist? 156 (61.9)
You can delegate a part of the tasks? 229 (90.9)
There is no financial compensation? 159 (63.1)
During the study cooperation with the general practitioner is required? 186 (73.8)
During the study cooperation with a medical specialist is required? 121 (48.0)
You can invite all patients for participation directly in the pharmacy (no selection needed)? 211 (83.7)
You have to make a selection before inviting patients yourself? 203 (80.6)
You can invite patients for participation by email? 219 (86.9)
You can invite patients for participation only personally or by telephone? 166 (65.9)
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Conclusion
Pharmacists’ participation in practice research depends on the
research design. Clear descriptions, possibilities for flexible
time management, simple patient inclusion and task delega-
tion can all increase this participation. Researchers should
acknowledge that cooperation with many different healthcare
professionals may pose a barrier towards participation in
practice research and should develop strategies to address this.
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